Literature DB >> 20373913

Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.

Rajiv Dhand.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20373913      PMCID： PMC3116637          DOI： 10.1089/jamp.2010.0818

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN： 1941-2711            Impact factor:   2.849


× No keyword cloud information.
  16 in total

Review 1.  Design principles of liquid nebulization devices currently in use.

Authors:  Joseph L Rau
Journal:  Respir Care       Date:  2002-11       Impact factor: 2.258

2.  Dose counting and the use of pressurized metered-dose inhalers: running on empty.

Authors:  Nancy Sander; Sandra J Fusco-Walkert; Julia M Harder; Bradley E Chipps
Journal:  Ann Allergy Asthma Immunol       Date:  2006-07       Impact factor: 6.347

3.  Human variation in the peripheral air-space deposition of inhaled particles.

Authors:  W D Bennett; G C Smaldone
Journal:  J Appl Physiol (1985)       Date:  1987-04

Review 4.  The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future.

Authors:  John Denyer; Tony Dyche
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

Review 5.  In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system.

Authors:  Lucy E A Hardaker; Ross H M Hatley
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

6.  Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease.

Authors:  Nicola Goodman; Mike Morgan; Kurt Nikander; Sarah Hinch; Steven Coughlin
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

7.  Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study.

Authors:  Robert E Van Dyke; Kurt Nikander
Journal:  Respir Care       Date:  2007-02       Impact factor: 2.258

8.  Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis.

Authors:  Paul S McNamara; Pamela McCormack; Alison J McDonald; Louisa Heaf; Kevin W Southern
Journal:  J Cyst Fibros       Date:  2009-05-15       Impact factor: 5.482

9.  Effects of various inhalation modes on the deposition of radioactive pressurized aerosols.

Authors:  S P Newman; D Pavia; N Garland; S W Clarke
Journal:  Eur J Respir Dis Suppl       Date:  1982

10.  Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency.

Authors:  P Brand; M Schulte; M Wencker; C H Herpich; G Klein; K Hanna; T Meyer
Journal:  Eur Respir J       Date:  2009-02-27       Impact factor: 16.671
View more
  5 in total

1.  Acute hemodynamic effects of nebulized iloprost via the I-neb Adaptive Aerosol Delivery system in pulmonary hypertension.

Authors:  Manuel J Richter; Hossein A Ghofrani; Robert Voswinckel; Werner Seeger; Richard Schulz; Frank Reichenberger; Henning Gall
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 2.  Advances in device and formulation technologies for pulmonary drug delivery.

Authors:  John Gar Yan Chan; Jennifer Wong; Qi Tony Zhou; Sharon Shui Yee Leung; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2014-04-12       Impact factor: 3.246

3.  Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial.

Authors:  Manuel J Richter; Barbara Stollfuß; Alexander Roitenberg; Frank Kleinjung; Valentin Graeff; Sabine Berghaus; Christian Müller; Hossein-Ardeschir Ghofrani
Journal:  Pulm Circ       Date:  2018-08-20       Impact factor: 3.017

Review 4.  Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.

Authors:  Raj Kumar; Piyush Mehta; Konathala Ravi Shankar; Manju A K Rajora; Yogendra Kumar Mishra; Ebrahim Mostafavi; Ajeet Kaushik
Journal:  Pharm Res       Date:  2022-05-12       Impact factor: 4.580

5.  Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension.

Authors:  Heidi M Mansour
Journal:  Pulm Circ       Date:  2018 Oct-Dec       Impact factor: 3.017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.